NARSAD
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Leonardo Tondo, M.D. (Independent Investigator 2003) of Harvard University, will evaluate effects of short-term treatments in acute episodes of mania or hypomania (antipsychotic or antimanic agents), or bipolar major depression (antidepressants), or maintained long-term mood-stabilizing treatments (typically with lithium carbonate, and less often with carbamazepine or sodium valproate). The effects of the treatments will be evaluated on the course of the bipolar disorder, including episode type, severity, duration, number of episodes and rate. Comparisons will involve the same patients before and during dissimilar treatments as well as those who receive the different types of treatments. The study should clarify characteristics of patients who elect or are chosen for one treatment strategy or the other. The study is based on a new database and electronic medical record (EMR) that includes variables of interest for each month, and derived from illness datasheets and charts that have been used for all patients since their intake into the mood disorder clinic, Centro Bini, in Cagliari, Sardinia, since 1977. This database records the patient's mood status (euthymia, manic, depressive, mixed), mood severity (mild, moderate, severe depression; hypomania, mania, hospitalization), mood modifiers (psychotic features, mixed states, and melancholia), and treatments (categorized as antidepressants, antipsychotics, mood stabilizers). Other available variables of interest are: sex, marital status, education, employment, family history, diagnosis, type of polarity at first episode, age at illness onset, at intake, at the start of the therapy; follow-up, type of treatment and its duration, suicidal behavior, and substance use disorder. Dr. Tondo will seek information on: modifications of morbidity associated with the treatments provided, course patterns according to the more prevalent episode sequences (mania-depression-interval, depression-mania-interval, circular), seasonality in specific clinical subgroups, differences between patients who adhere to treatment and those who modify or discontinue treatment. This information should help to guide treatment strategies for patients with different clinical and demographic characteristics.

Program Area: MOOD DISORDERS\Bipolar

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award Application Deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Awards Earliest Start Date: September 15, 2008

2009 Independent Investigator Award Application Deadline: March 5, 2009

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009
NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us